Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sporadic Use of Antibiotics in Older Adults and the Risk of Dementia: A Nested Case–Control Study Based on German Health Claims Data
Elena Rakuša, Anne Fink, Gültekin Tamgüney, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 4, pp. 1329-1339
Closed Access | Times Cited: 10

Showing 10 citing articles:

Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Dong-oh Seo, David M. Holtzman
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 86-94
Open Access | Times Cited: 78
Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives
Simone Lista, Antonio Munafò, Filippo Caraci, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102659-102659
Closed Access | Times Cited: 2
Modulation of Alzheimer’s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a
Wenlin Hao, Qinghua Luo, Inge Tomic, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
An emerging role for the gut microbiome in tauopathy
Yiyang Zhu, Wade Self, David M. Holtzman
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00423-e00423
Open Access | Times Cited: 3
Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?
Shanshan Zhang, Jing Lu, Ziqi Jin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review
Thomas J. Farrer, Jonathan D. Moore, Morgan Chase, et al.
Pathogens (2024) Vol. 13, Iss. 11, pp. 974-974
Open Access | Times Cited: 2
The Complex Relationship Between Gut Microbiota and Alzheimer’s Disease: A Systematic Review
Xuan-Peng Zhou, Lei Sun, Wenhao Liu, et al.
Ageing Research Reviews (2024), pp. 102637-102637
Open Access | Times Cited: 2
Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults
Yiqing Wang, Zhen Zhou, Jonathan Broder, et al.
Neurology (2024) Vol. 104, Iss. 1
Closed Access | Times Cited: 2
Symposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?
Joia K. Capocchi, Claudia Figueroa‐Romero, Sage J. B. Dunham, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 41, pp. e1295242024-e1295242024
Closed Access | Times Cited: 1
Inhibiting mtDNA transcript translation alters Alzheimer's disease‐associated biology
Alexander P. Gabrielli, Lesya Novikova, Amol Ranjan, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 1
Page 1

Scroll to top